Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Ethicon Sells Its Advanced Sterilization Products for $2.7 Billion
Johnson & Johnson (NYSE: JNJ) subsidiary Ethicon last week sold its advanced sterilization products (ASP) business to Fortive Corporation (NYSE: FTV) for $2.7 billion. The ASP business is a global provider of innovative sterilization and disinfection solutions. It generated adjusted EBITDA margin of approximately 25% (unaudited) in 2017. Fortive is a diversified industrial growth company comprised of professional instrumentation and industrial technologies businesses. Fortive’s brands generated revenue of $6.7 billion in 2017. ASP’s products include the STERRAD system for sterilizing instruments and the EVOTECH and ENDOCLENS system for endoscope reprocessing and cleaning.... Read More »
New Enterprise Associates Adds Paladina Health to Its Portfolio
New Enterprise Associates (NEA) has a strong healthcare portfolio, filled with digital health, population health management and physician practices. On June 6, the private equity firm added another physician group, Paladina Health, for a reported $100 million. It’s not surprising that the bidding was “highly competitive,” according to a CNBC source, and that there were other private equity firms in the process. What is interesting is the nod that “a large retailers and pharmacy chain” was also in the hunt. Hello, CVS Health (NYSE: CVS)? Paladina Health, a subsidiary of DaVita Inc. (NYSE: DVA), is a primary care practice with 53 clinics in 10 states. It... Read More »
Health Care M&A Weekly Deals, The Week Ending June 8, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Axovant Sciences Ltd. Exclusive worldwide license to OXB-102 $30 million Gilead Sciences, Inc. Exclusive license to 2 immunization technologies $10 million Yakult Honsha Co., Ltd. Exclusive license to... Read More »
Talk of a Bubble in Healthcare Services Slows Some Deals
Yes, the B-word is being bandied about among deal makers these days. Talk of a bubble, particularly in healthcare services, is becoming more open. We heard it often at a recent breakfast meeting of healthcare investors, and again and again in conversations since. In May, some 130 transactions were made public, representing a 26% decline compared with April’s out-sized 175 transactions, and 8% below the 142 deals recorded in May 2017. Deals in the services sectors accounted for 56% of the month’s total, which is much lower than their share in April (62%) and the same month a year earlier (65%). It’s not just that the technology sectors are picking up some steam after a long drought,... Read More »
U.S. Hospital Transaction Trends, at Mid-Year
It just might be “the pause that refreshes.” Or it could be the beginning of a painful contraction in the hospital market. In the first five months of 2018, 34 deals—representing definitive agreements and closures—have been announced. That’s the same number reported in the first five months of 2017. The difference lies behind the number of deals, of course. In the first five months of 2017, several large hospital systems merged or were acquired. Among the deals were Mississippi Baptist Health System (four hospitals) and Baptist Memorial Health (17 hospitals); IASIS Healthcare (17 hospitals) and Steward Health Care (18 hospitals); and Steward Health’s acquisition of eight hospitals from... Read More »
Health Care M&A Weekly Deals, The Week Ending June 1, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Denali Therapeutics Inc. F-star Gamma Ltd. $24 million Zai Lab Limited Exclusive worldwide license to protein therapeutics N/A eHealth Acquirer Target Price ResMed Inc. HEALTHCAREfirst N/A Aquiline... Read More »
Myriad Genetics Acquires Counsyl, a Women’s Health Lab
Myriad Genetics (NASDAQ: MYGN) agreed to pay $375 million to acquire privately held Counsyl, Inc., which operates a high-complexity clinical laboratory dedicated to women’s health. Counsyl’s lab services include carrier and non-invasive prenatal screening, including its Foresight Carrier Screen, Prelude Prenatal Screen, Reliant Cancer Screen, as well as supporting services through Counsyl Complete, a suite of solutions that integrate Counsyl screening into clinical workflows and patients’ lives. Since the company’s founding, Counsyl has championed key advances in screening for women and their families, screening more than 850,000 patients, serving more than 17,000... Read More »
MedPlast Adds Integer’s Surgical and Orthopedics Lines
MedPlast Inc., a portfolio company of JLL Partners and Water Street Healthcare Partners, announced the largest deal in the Medical Device sector in May 2018. The company, which provides integrated custom plastic processing solutions for finished medical devices, acquired the advanced surgical and orthopedics lines (ASO) from Integer (NYSE: ITGR) for $600 million. The transaction includes 10 manufacturing facilities. The ASO business comprises products and services for the laparoscopy, general surgery, biopsy and drug delivery, arthroscopic devices and components and orthopedic markets. Integer, formerly known as Greatbatch, rebranded in 2016 under the Integer name. With this acquisition,... Read More »
Meridian Sells to WellCare Health Plans for $2.5 Billion
WellCare Health Plans, Inc. (NYSE: WCG) struck a deal to acquire privately held Meridian, which operates Medicaid plans in Illinois and Michigan, as well as MeridianRx, a pharmacy benefit manager (PBM). The all-cash price is $2.5 billion. Meridian expects to generate more than $4.3 billion in total revenue in 2018. Through its subsidiaries, Meridian Health Plan of Michicgan, Inc. and Meridian Health Plan of Illinois, Inc., the company serves approximately 1.1 million Medicaid, Medicare Advantage, integrated dual-eligible and Health Insurance Marketplace members as or May 1, 2018, in Michigan, Illinois, Indiana and Ohio. This transaction is expected to close by the end of 2018. For... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
